Apotea AB (publ), Sweden’s leading online pharmacy by market share, has successfully completed its IPO on Nasdaq Stockholm. The IPO attracted very strong interest from Swedish and international institutions as well as from the general public in Sweden. The IPO was heavily oversubscribed.
Funds managed by Capital Group, Nordea Asset Management, WCM Investment Management, Ramsbury Invest and AMF Aktiefond Småbolag acted as cornerstone investors in the transaction. Cornerstone investors agreed to subscribe for shares in the offering of up to SEK 975m, corresponding to c. 52% of the total offering. The IPO was priced at SEK 58 per share, corresponding to a total market capitalisation of SEK 6bn. Trading commenced on December 6, 2024, under the ticker “APOTEA”.

Published: 6 Dec, 2024

Contact

Jonas Ström

Jonas Ström

CEO

jonas.strom@abgsc.se +46 8 566 294 68
Johan Lindén

Johan Lindén

Investment Banking

johan.linden@abgsc.se +46 8 566 286 14
Andreas Ekenberg

Andreas Ekenberg

Investment Banking

Andreas.Ekenberg@abgsc.se +46 8 566 286 65
Johan Brown

Johan Brown

Investment Banking

johan.brown@abgsc.se +46 8 566 286 51
Hedda Cederlund

Hedda Cederlund

Investment Banking

hedda.cederlund@abgsc.se +46 8 566 294 74
Erik Skog

Erik Skog

Co-Head of ECM and Head of Investment Banking Sweden

erik.skog@abgsc.se +46 8 566 294 71
Oskar Wikberg

Oskar Wikberg

Investment Banking (ECM)

Oskar.Wikberg@abgsc.se +46 8 566 294 79
Jonathan Boklund

Jonathan Boklund

Investment Banking (ECM)

Jonathan.Boklund@abgsc.se +46 8 566 286 58

Estelle De Geer

Investment Banking

estelle.degeer@abgsc.se +46 8 566 286 54